A new approach to tumor therapy combines two problematic cancer-fighting tools: tumor-targeted T cells and gene therapy. The T cells deliver a gene therapy vector to tumor cells, ensuring their destruction (pages 1073–1081).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Katie Ris
References
Cole, C. et al. Nat. Med. 11, 1073–1081 (2005).
Heslop, H.E. et al. Nat. Med. 2, 551–555 (1996).
Walter, E.A. et al. N. Engl. J. Med. 333, 1038–1044 (1995).
Dudley, M.E. et al. J. Clin. Oncol. 23, 2346–2357 (2005).
Cavazzana-Calvo, M. et al. Blood 94, 367a (1999).
Hacein-Bey-Abina, S. et al. Science 302, 415–419 (2003).
Yotnda, P. et al. Blood 104, 2272–2280 (2004).
Pizzato, M. et al. Gene Ther. 8, 1088–1096 (2001).
Dixon, A.E. et al. Am. J. Physiol. Lung Cell Mol. Physiol. 279, L583–L591 (2000).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rooney, C. Hitchhiker's guide to the T cell. Nat Med 11, 1051–1052 (2005). https://doi.org/10.1038/nm1005-1051
Issue Date:
DOI: https://doi.org/10.1038/nm1005-1051
